KYMR
Kymera Therapeutics Inc

837
Mkt Cap
$6.36B
Volume
1.2M
52W High
$103.00
52W Low
$19.45
PE Ratio
-21.18
KYMR Fundamentals
Price
$77.91
Prev Close
$79.57
Open
$79.48
50D MA
$79.67
Beta
1.63
Avg. Volume
861,084.94
EPS (Annual)
-$3.69
P/B
4.01
Rev/Employee
$164,752.10
$5,808.19
Loading...
Loading...
News
all
press releases
Hudson Bay Capital Management LP Grows Stock Holdings in Kymera Therapeutics, Inc. $KYMR
Hudson Bay Capital Management LP grew its position in Kymera Therapeutics, Inc. (NASDAQ:KYMR - Free Report) by 362.7% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 23,134 shares of the company's stock after buying an additional 18...
MarketBeat·12m ago
News Placeholder
More News
News Placeholder
Nextech Trims Kymera at a Recent High think Foolishly before acting.
Key PointsSold 62,013 shares of Kymera Therapeutics; estimated transaction value $4.19 million (based on mean unadjusted close for the quarter...
Nasdaq News: Markets·4d ago
News Placeholder
HighVista Strategies LLC Makes New $890,000 Investment in Kymera Therapeutics, Inc. $KYMR
HighVista Strategies LLC acquired a new position in Kymera Therapeutics, Inc. (NASDAQ:KYMR - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and...
MarketBeat·6d ago
News Placeholder
Holocene Advisors LP Acquires New Holdings in Kymera Therapeutics, Inc. $KYMR
Holocene Advisors LP bought a new stake in Kymera Therapeutics, Inc. (NASDAQ:KYMR - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities...
MarketBeat·6d ago
News Placeholder
Jefferies Financial Group Initiates Coverage on Kymera Therapeutics (NASDAQ:KYMR)
Jefferies Financial Group initiated coverage on shares of Kymera Therapeutics in a report on Monday. They issued a "buy" rating for the company...
MarketBeat·7d ago
News Placeholder
Boxer Capital Management LLC Lowers Holdings in Kymera Therapeutics, Inc. $KYMR
Boxer Capital Management LLC reduced its position in shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR - Free Report) by 26.1% in the 3rd quarter, according to its most recent filing with the...
MarketBeat·8d ago
News Placeholder
Braidwell LP Takes $15.66 Million Position in Kymera Therapeutics, Inc. $KYMR
Braidwell LP purchased a new position in Kymera Therapeutics, Inc. (NASDAQ:KYMR - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange...
MarketBeat·8d ago
News Placeholder
Kymera Therapeutics, Inc. $KYMR Stock Position Lessened by Avoro Capital Advisors LLC
Avoro Capital Advisors LLC reduced its stake in Kymera Therapeutics, Inc. (NASDAQ:KYMR - Free Report) by 3.1% in the third quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·9d ago
News Placeholder
Insider Selling: Kymera Therapeutics (NASDAQ:KYMR) COO Sells 25,758 Shares of Stock
Kymera Therapeutics, Inc. (NASDAQ:KYMR - Get Free Report) COO Jeremy Chadwick sold 25,758 shares of Kymera Therapeutics stock in a transaction dated Wednesday, March 11th. The stock was sold at an...
MarketBeat·11d ago
News Placeholder
Kymera Therapeutics (NASDAQ:KYMR) COO Jeremy Chadwick Sells 25,758 Shares
Kymera Therapeutics, Inc. (NASDAQ:KYMR - Get Free Report) COO Jeremy Chadwick sold 25,758 shares of the business's stock in a transaction that occurred on Wednesday, March 11th. The shares were sold...
MarketBeat·11d ago
<
1
2
...
>

Latest KYMR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.